QQQ   354.94 (-1.30%)
AAPL   172.82 (-1.85%)
MSFT   311.59 (-1.87%)
META   298.57 (-0.75%)
GOOGL   127.45 (-2.79%)
AMZN   127.12 (-3.16%)
TSLA   248.13 (+0.46%)
NVDA   421.85 (-0.09%)
NIO   8.52 (+2.04%)
BABA   86.19 (-1.18%)
AMD   96.36 (-1.05%)
T   15.03 (-0.20%)
F   12.51 (-0.56%)
MU   68.22 (-0.52%)
CGC   0.96 (+1.29%)
GE   110.00 (-1.54%)
DIS   80.41 (-0.74%)
AMC   8.26 (+1.47%)
PFE   32.72 (-0.79%)
PYPL   58.79 (-0.12%)
NFLX   383.08 (-0.45%)
QQQ   354.94 (-1.30%)
AAPL   172.82 (-1.85%)
MSFT   311.59 (-1.87%)
META   298.57 (-0.75%)
GOOGL   127.45 (-2.79%)
AMZN   127.12 (-3.16%)
TSLA   248.13 (+0.46%)
NVDA   421.85 (-0.09%)
NIO   8.52 (+2.04%)
BABA   86.19 (-1.18%)
AMD   96.36 (-1.05%)
T   15.03 (-0.20%)
F   12.51 (-0.56%)
MU   68.22 (-0.52%)
CGC   0.96 (+1.29%)
GE   110.00 (-1.54%)
DIS   80.41 (-0.74%)
AMC   8.26 (+1.47%)
PFE   32.72 (-0.79%)
PYPL   58.79 (-0.12%)
NFLX   383.08 (-0.45%)
QQQ   354.94 (-1.30%)
AAPL   172.82 (-1.85%)
MSFT   311.59 (-1.87%)
META   298.57 (-0.75%)
GOOGL   127.45 (-2.79%)
AMZN   127.12 (-3.16%)
TSLA   248.13 (+0.46%)
NVDA   421.85 (-0.09%)
NIO   8.52 (+2.04%)
BABA   86.19 (-1.18%)
AMD   96.36 (-1.05%)
T   15.03 (-0.20%)
F   12.51 (-0.56%)
MU   68.22 (-0.52%)
CGC   0.96 (+1.29%)
GE   110.00 (-1.54%)
DIS   80.41 (-0.74%)
AMC   8.26 (+1.47%)
PFE   32.72 (-0.79%)
PYPL   58.79 (-0.12%)
NFLX   383.08 (-0.45%)
QQQ   354.94 (-1.30%)
AAPL   172.82 (-1.85%)
MSFT   311.59 (-1.87%)
META   298.57 (-0.75%)
GOOGL   127.45 (-2.79%)
AMZN   127.12 (-3.16%)
TSLA   248.13 (+0.46%)
NVDA   421.85 (-0.09%)
NIO   8.52 (+2.04%)
BABA   86.19 (-1.18%)
AMD   96.36 (-1.05%)
T   15.03 (-0.20%)
F   12.51 (-0.56%)
MU   68.22 (-0.52%)
CGC   0.96 (+1.29%)
GE   110.00 (-1.54%)
DIS   80.41 (-0.74%)
AMC   8.26 (+1.47%)
PFE   32.72 (-0.79%)
PYPL   58.79 (-0.12%)
NFLX   383.08 (-0.45%)
Positive News SentimentPositive News
NASDAQ:CGEM

Cullinan Oncology (CGEM) News Today

$9.90
+0.21 (+2.17%)
(As of 11:48 AM ET)
Compare
Today's Range
$9.59
▼
$10.06
50-Day Range
$9.49
▼
$11.35
52-Week Range
$7.78
▼
$13.98
Volume
23,030 shs
Average Volume
237,665 shs
Market Capitalization
$423.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoHarbor Capital Advisors Inc. Acquires Shares of 13,894 Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - September 21 at 5:10 AM
MarketBeat logoShort Interest in Cullinan Oncology, Inc. (NASDAQ:CGEM) Expands By 33.2%
americanbankingnews.com - September 16 at 2:18 AM
marketbeat.com logoBVF Inc. IL Has $32.70 Million Stake in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - September 12 at 4:47 AM
msn.com logoCullinan Oncology: Inexplicably Trading Below Cash Despite Robust Data
msn.com - September 11 at 6:23 PM
marketbeat.com logoCHI Advisors LLC Buys 31,916 Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - August 11 at 10:22 PM
markets.businessinsider.com logoBTIG Sticks to Their Buy Rating for Cullinan Management (CGEM)
markets.businessinsider.com - August 11 at 7:08 PM
marketbeat.com logoHC Wainwright Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $34.00
marketbeat.com - August 11 at 2:23 PM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 10 at 8:10 AM
finance.yahoo.com logoCullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
finance.yahoo.com - August 9 at 9:55 AM
finance.yahoo.com logoREZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
finance.yahoo.com - August 3 at 9:32 PM
markets.businessinsider.com logoAnalyst Ratings for Cullinan Oncology
markets.businessinsider.com - July 7 at 1:41 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Cullinan Management (CGEM)
markets.businessinsider.com - July 7 at 7:48 AM
marketbeat.com logoAssenagon Asset Management S.A. Purchases 138,330 Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - July 7 at 4:51 AM
msn.com logoTD Cowen Initiates Coverage of Cullinan Oncology (CGEM) with Outperform Recommendation
msn.com - June 15 at 10:41 PM
markets.businessinsider.com logoAnalyst Expectations for Cullinan Oncology's Future
markets.businessinsider.com - June 15 at 5:41 PM
markets.businessinsider.com logoExpert Ratings for Cullinan Oncology
markets.businessinsider.com - June 15 at 12:41 PM
marketbeat.com logoAtom Investors LP Has $1.13 Million Stake in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - June 14 at 5:54 AM
finance.yahoo.com logoWhy Shares of Cullinan Oncology Jumped This Week
finance.yahoo.com - June 9 at 5:40 PM
markets.businessinsider.com logoCullinan Management (CGEM) Receives a Buy from SVB Securities
markets.businessinsider.com - June 7 at 9:00 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Cullinan Management (CGEM)
markets.businessinsider.com - June 5 at 11:05 AM
markets.businessinsider.com logoCullinan Management (CGEM) Gets a Buy from BTIG
markets.businessinsider.com - May 30 at 8:01 AM
msn.com logoHC Wainwright & Co. Reiterates Cullinan Oncology (CGEM) Buy Recommendation
msn.com - May 26 at 1:27 PM
msn.com logoCullinan gains as early trial for cancer drug indicates complete remission
msn.com - May 26 at 1:27 PM
finance.yahoo.com logoCullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023
finance.yahoo.com - May 25 at 5:25 PM
markets.businessinsider.com logoSVB Securities Keeps Their Buy Rating on Cullinan Management (CGEM)
markets.businessinsider.com - May 15 at 1:10 PM
msn.com logoHC Wainwright & Co. Maintains Cullinan Oncology (CGEM) Buy Recommendation
msn.com - May 12 at 3:17 PM
marketbeat.com logoCullinan Oncology (NASDAQ:CGEM) Price Target Cut to $49.00
marketbeat.com - May 12 at 8:33 AM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 8:02 PM
finance.yahoo.com logoCullinan Oncology to Present First Clinical Data Evaluating Novel Anti-MICA/B Antibody, CLN-619, in Patients with Advanced Solid Tumors at ASCO 2023
finance.yahoo.com - April 26 at 2:58 PM
finance.yahoo.com logoCullinan Oncology to Participate in Stifel’s 2023 Targeted Oncology Days
finance.yahoo.com - April 20 at 9:20 AM
benzinga.com logoCullinan Oncology Inc (CGEM) is down -2.57% in a Week, Should You Accumulate?
benzinga.com - April 2 at 12:38 PM
markets.businessinsider.com logoWhat 4 Analyst Ratings Have To Say About Cullinan Oncology
markets.businessinsider.com - March 27 at 3:36 PM
finance.yahoo.com logoCullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines
finance.yahoo.com - March 27 at 10:36 AM
seekingalpha.com logoORIC Pharma gains as H.C. Wainwright upgrades on solid tumor candidate
seekingalpha.com - March 23 at 10:51 AM
finance.yahoo.com logoCullinan Oncology to Present New Preclinical Data for CLN-619 and CLN-617 at the 2023 American Association for Cancer Research Annual Meeting
finance.yahoo.com - March 14 at 6:51 PM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Cullinan Management (CGEM)
markets.businessinsider.com - March 13 at 9:41 AM
marketbeat.com logoHsbc Holdings PLC Takes Position in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - March 12 at 4:20 AM
marketbeat.com logoMartingale Asset Management L P Makes New $398,000 Investment in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - March 10 at 5:57 AM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 9 at 10:19 AM
finance.yahoo.com logoCullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 9 at 10:19 AM
finance.yahoo.com logoCullinan Oncology to Participate in Cowen’s 43rd Annual Health Care Conference
finance.yahoo.com - February 27 at 8:59 PM
marketbeat.com logoRubric Capital Management LP Increases Position in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - February 17 at 11:49 AM
marketbeat.com logoBrokers Offer Predictions for Cullinan Oncology, Inc.'s Q3 2023 Earnings (NASDAQ:CGEM)
marketbeat.com - February 17 at 9:38 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Cullinan Management (CGEM)
markets.businessinsider.com - February 14 at 2:10 PM
finance.yahoo.com logoCullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed
finance.yahoo.com - February 13 at 7:43 PM
marketbeat.com logoJump Financial LLC Has $278,000 Position in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - February 10 at 5:20 AM
marketbeat.com logoVictory Capital Management Inc. Buys New Stake in Cullinan Oncology, Inc. (NASDAQ:CGEM)
marketbeat.com - February 9 at 4:19 AM
marketbeat.com logoCullinan Oncology (NASDAQ:CGEM) Trading Down 4.6% Following Analyst Downgrade
marketbeat.com - February 3 at 10:27 AM
marketbeat.com logoMorgan Stanley Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $19.00
marketbeat.com - February 3 at 9:59 AM
finance.yahoo.com logoCullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB Securities Global Biopharma Conference
finance.yahoo.com - February 2 at 7:55 PM
Get Cullinan Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter.



CGEM Media Mentions By Week

CGEM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGEM
News Sentiment
▼
1.80

0.50
▲
Average
Medical
News Sentiment

CGEM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGEM Articles
This Week
▼
1

1
▲
CGEM Articles
Average Week

Get Cullinan Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CGEM) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -